Digital pharmacy UpScript Health gears up for sale

  • Arizona company led by CEO Peter Ax
  • Digital pharmacy focused in women’s and men’s health
  • Process follows Amazon buy of online pharmacy PillPack

UpScript Health, whose online services help patients get their medications faster and easier, is headed to the auction block, Buyouts has learned.

Berkery Noyes has been engaged to advise the Scottsdale, Arizona, direct-to-consumer digital pharmacy, with a process expected to launch later this summer, the people said.

The expected process comes on the heels of the sale of the asset’s larger rival, PillPack. The online pharmacy reportedly commanded a $1 billion valuation just a couple of weeks ago through its sale to Amazon.

UpScript, which to date has not raised any outside institutional capital, posts about $5 million of Ebitda on $30 million of revenue, one of the people said.

The digital pharmacy, which operates in 49 states, offers a fully integrated model through which consumers obtain medications directly from manufacturers.

Consumers using UpScript can order products on manufacturers’ websites, connect virtually with physicians, obtain prescriptions through licensed pharmacies, and ultimately receive their orders via home delivery.

UpScript focuses in areas including women’s and men’s health, skin and eye conditions, as well as lifestyle-like segments such as hearing loss and weight loss.

Existing partners include Teva Pharmaceutical, Somna Therapeutics and Obagi Medical, to name a few.

UpScript is led by CEO and Managing Partner Peter Ax, former head of the private equity placement group and senior vice president at Lehman Brothers.

Representatives of UpScript couldn’t immediately be reached, while those at Berkery Noyes declined comment.

Action Item: Learn more about UpScript